trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Bone Marrow Neoplasms D019046 2 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Cat Diseases D002371 12 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Retinoblastoma D012175 12 associated lipids
Genomic Instability D042822 7 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Fan J et al. [Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine]. 2006 Zhonghua Zhong Liu Za Zhi pmid:17533736
de Boer J et al. Inhibition of histone acetylation as a tool in bone tissue engineering. 2006 Tissue Eng. pmid:17518660
Takahashi K et al. Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer. 2006 Int. J. Oncol. pmid:16391785
Bai T et al. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells. 2006 Int. J. Oncol. pmid:16391806
Pazmany T and Tomasi TB The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells. 2006 J. Neuroimmunol. pmid:16360884
Minetti GC et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. 2006 Nat. Med. pmid:16980968
Lee KY et al. NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. 2006 J. Immunol. pmid:16365456
Ohnishi K [Therapeutic strategies for patients with relapsed acute promyelocytic leukemia]. 2006 Rinsho Ketsueki pmid:16986710
Dowdy SC et al. Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells. 2006 Mol. Cancer Ther. pmid:17121923
Yang QC et al. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. 2006 J. Exp. Clin. Cancer Res. pmid:17310851
Uchida H et al. Human endometrial cytodifferentiation by histone deacetylase inhibitors. 2006 Hum. Cell pmid:16643606
Stefanovsky V and Moss T Regulation of rRNA synthesis in human and mouse cells is not determined by changes in active gene count. 2006 Cell Cycle pmid:16582637
Wang Q et al. Histone deacetylation is required for orderly meiosis. 2006 Cell Cycle pmid:16582639
Magnaghi-Jaulin L and Jaulin C Histone deacetylase activity is necessary for chromosome condensation during meiotic maturation in Xenopus laevis. 2006 Chromosome Res. pmid:16628502
Pavan Kumar P et al. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. 2006 Mol. Cell pmid:16630892
Li GC et al. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest. 2006 Int. J. Urol. pmid:16771729
Zhou C et al. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. 2006 Int. J. Oncol. pmid:16773209
Zampetaki A et al. TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. 2006 Biochem. Biophys. Res. Commun. pmid:16814255
Jüngel A et al. Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis. 2006 Ann. Rheum. Dis. pmid:16284094
Nygård M et al. Thyroid hormone-mediated negative transcriptional regulation of Necdin expression. 2006 J. Mol. Endocrinol. pmid:16720720
Armstrong K et al. NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells. 2006 Prostate pmid:16683270
Sestáková B and Vachtenheim J Distinct co-regulation of endogenous versus transfected MITF-dependent tyrosinase promoter. 2006 Folia Biol. (Praha) pmid:17116288
Balasubramaniyan V et al. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. 2006 Neuroscience pmid:17084985
Zhang Y et al. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene. 2006 Mol. Cell. Biol. pmid:16943418
Stewart MD et al. Dynamic regulation of histone modifications in Xenopus oocytes through histone exchange. 2006 Mol. Cell. Biol. pmid:16943430
Mühlisch J et al. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood. 2006 Oncogene pmid:16186793
Sun C et al. Anticancer activities of trichostatin A on maligant lymphoid cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219961
Kim HR et al. Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway? 2006 Exp. Mol. Med. pmid:17202837
van den Boom J et al. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction. 2006 Int. J. Cancer pmid:16865689
Bai J et al. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. 2006 Biochem. Biophys. Res. Commun. pmid:16904634
Charrier C et al. Synthesis of rigid trichostatin A analogs as HDAC inhibitors. 2006 Bioorg. Med. Chem. Lett. pmid:16904890
Okamoto H et al. Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1). 2006 J. Atheroscler. Thromb. pmid:16908950
Seo H et al. An ex vivo method for rapid generation of monoclonal antibodies (ADLib system). 2006 Nat Protoc pmid:17406441
Araki H et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. 2006 Exp. Hematol. pmid:16459182
Sonnemann J et al. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. 2006 Int. J. Oncol. pmid:16465382
Pedram M et al. Telomere position effect and silencing of transgenes near telomeres in the mouse. 2006 Mol. Cell. Biol. pmid:16479005
Rybouchkin A et al. Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer. 2006 Biol. Reprod. pmid:16481594
Banchio C et al. Role of histone deacetylase in the expression of CTP:phosphocholine cytidylyltransferase alpha. 2006 J. Biol. Chem. pmid:16484221
Weaver IC et al. Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16484373
Cecconi D et al. Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. 2005 Nov-Dec J. Proteome Res. pmid:16335935
Garcia BA et al. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. 2005 Nov-Dec J. Proteome Res. pmid:16335948
Chen LJ et al. [hCG-PLZF-RARalpha/hCG-RARalpha-PLZF transgenic mice developing into leukemia]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:16403252
Liu H et al. [Antineoplastic effect of valproic acid and trichostatin on HL-60 and K562 cells]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:16403260
Chen J and Kang JH Quercetin and trichostatin A cooperatively kill human leukemia cells. 2005 Pharmazie pmid:16320950
Wei M et al. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. 2005 Cancer Res. pmid:16322213
Marchion DC et al. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta. 2005 Clin. Cancer Res. pmid:16322310
Farrajota K et al. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. 2005 Arthritis Rheum. pmid:15641079
Jori FP et al. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells. 2005 Cell Death Differ. pmid:15459751
Hammond SM et al. Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. 2005 Leuk. Res. pmid:15541480
Liu AL et al. [A new target of cancer therapy: advances in the study of histone deacetylase]. 2005 Yao Xue Xue Bao pmid:16196262
Zhang Y et al. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. 2005 Mol. Cell. Biol. pmid:16135786
Ren C et al. Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors. 2005 J. Am. Soc. Mass Spectrom. pmid:16099169
Shinji C et al. Design and synthesis of phthalimide-type histone deacetylase inhibitors. 2005 Bioorg. Med. Chem. Lett. pmid:16137884
Danaher RJ et al. Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. 2005 J. Neurovirol. pmid:16036811
Laribee RN and Klemsz MJ Histone H4 HDAC activity is necessary for expression of the PU.1 gene. 2005 Biochim. Biophys. Acta pmid:16139904
Blagosklonny MV et al. Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. 2005 Cancer Res. pmid:16103091
Choi JH et al. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:16141407
Krouwels IM et al. A glue for heterochromatin maintenance: stable SUV39H1 binding to heterochromatin is reinforced by the SET domain. 2005 J. Cell Biol. pmid:16103223
Ishihara K [Role of eosinophils in allergic inflammation]. 2005 Yakugaku Zasshi pmid:16141691
Lu Q et al. Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. 2005 J. Med. Chem. pmid:16107152
Yanada M et al. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. 2005 Oncol. Rep. pmid:16142337
Uchida H et al. Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin. 2005 Endocrinology pmid:16123169
Su M et al. Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells. 2005 J. Biol. Chem. pmid:16087680
Somech R et al. The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation. 2005 J. Cell. Sci. pmid:16129885
Cho HH et al. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. 2005 J. Cell. Biochem. pmid:16088945
Illi B et al. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. 2005 Circ. Res. pmid:15705964
Jalonen U et al. Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. 2005 Biochem. Pharmacol. pmid:15710351
Schmittwolf C et al. In vivo haematopoietic activity is induced in neurosphere cells by chromatin-modifying agents. 2005 EMBO J. pmid:15660132
Kang J et al. Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells. 2005 Toxicol In Vitro pmid:15649630
Peltonen K et al. Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis. 2005 Pigment Cell Res. pmid:15892716
Schwahn DJ et al. Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes. 2005 Pigment Cell Res. pmid:15892717
Ranganathan P and Rangnekar VM Exploiting the TSA connections to overcome apoptosis-resistance. 2005 Cancer Biol. Ther. pmid:15908800
Rincón-Arano H et al. YY1 and GATA-1 interaction modulate the chicken 3'-side alpha-globin enhancer activity. 2005 J. Mol. Biol. pmid:15913647
Young DA et al. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. 2005 FEBS J. pmid:15819885
Canes D et al. Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo. 2005 Int. J. Cancer pmid:15499627
Yamaguchi K et al. Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. 2005 J. Biol. Chem. pmid:15994313
Zhao XY et al. Granulocyte-macrophage colony-stimulating factor induces de novo methylation of the p15 CpG island in hematopoietic cells. 2005 Cytokine pmid:15996479
Sato N et al. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. 2005 Clin. Cancer Res. pmid:16000561
Munshi A et al. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. 2005 Clin. Cancer Res. pmid:16000590
Sng JC et al. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation. 2005 Neurosci. Lett. pmid:16002216
Sonnemann J et al. Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines. 2005 Invest New Drugs pmid:15744585
Shetty S et al. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. 2005 Mol. Cell. Biol. pmid:15964798
Place RF et al. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. 2005 Biochem. Pharmacol. pmid:15950952
Wooten LG and Ogretmen B Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide. 2005 J. Biol. Chem. pmid:15951564
Komata T et al. Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells. 2005 Int. J. Oncol. pmid:15809727
Schroeder TM and Westendorf JJ Histone deacetylase inhibitors promote osteoblast maturation. 2005 J. Bone Miner. Res. pmid:16294278
Endo T et al. Changes in histone modifications during in vitro maturation of porcine oocytes. 2005 Mol. Reprod. Dev. pmid:15736133
Fan S et al. Valproic acid enhances gene expression from viral gene transfer vectors. 2005 J. Virol. Methods pmid:15737413
Bártová E et al. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. 2005 J. Cell. Sci. pmid:16254244
Xu S et al. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. 2005 J. Hum. Genet. pmid:15824892
Strait KA et al. Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad. 2005 Mol. Cancer Ther. pmid:15827334
Magner WJ and Tomasi TB Apoptotic and necrotic cells induced by different agents vary in their expression of MHC and costimulatory genes. 2005 Mol. Immunol. pmid:15829293
Hu J and Colburn NH Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. 2005 Mol. Cancer Res. pmid:15755876
Sato N et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. 2005 Oncogene pmid:15592528
Davidson SM et al. The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. 2005 Chembiochem pmid:15593114
Maxhimer JB et al. Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C). 2005 J. Thorac. Cardiovasc. Surg. pmid:15632825
Kondo T et al. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. 2005 Oncogene pmid:15637589
Senawong T et al. BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. 2005 Arch. Biochem. Biophys. pmid:15639232
Nambiar MP et al. Transcriptional induction of cholinesterase expression and protection against chemical warfare nerve agents. 2005 Chem. Biol. Interact. pmid:16429504
Zhao Y et al. Histone acetylation regulates both transcription initiation and elongation of hsp22 gene in Drosophila. 2005 Biochem. Biophys. Res. Commun. pmid:15607742